Estimated trade-off shown as a ratio* of the number of BC deaths averted to cases overdiagnosed from mammography screening
| Source | Ratio of BC deaths averted to cases overdiagnosed |
|---|---|
| UK’s Independent Panel on Breast Cancer Screening3 for women invited to screening from age 50 for next 20 years | 1:3 |
| Mandelblatt et al.29 Biennial screening from 50 to 74 years Biennial screening from 40 to 74 years | 1:2.71:2.6 |
| Hersch et al.30 (based on data from Barratt et al.31) for biennial screening from age 50 over 20 years) | 1:4-5 |
| Canadian Task Force32 for women aged 50-69 years screened biennially for 11 years | 1:4 |
| Paci et al. (Euroscreen)27 for biennial screening starting at 50-51 years (with follow-up to age 79) | 2:1 |
* Additional data provided in manuscript text.